Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Plethora Solutions Ltd.

Home Clinical Trial Sponsors and OrganizationsPlethora Solutions Ltd.

Plethora Solutions Ltd.

ACTIVE

United Kingdomwww.plethorasolutions.co.ukSubsidiary

Part of plethora solutions holdings plc

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

10

4 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

5

50.0%

Phase 2

3

30.0%

Trial Status Distribution

Active, not recruiting

4

40.0%

Completed

6

60.0%

Clinical Trials

Trials sponsored by this organization (10)

PSD502 in Subjects With Premature Ejaculation

Dec 2018121 participants

A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation

Sep 201030 participants

A Safety and Tolerability Study of Administration of PSD502

Dec 200921 participants

A Phase II, multi-centre, double-blind, randomised, placebo-controlled, 4-way cross-over, dose-range finding study to evaluate efficacy and safety and tolerability of PSD502 in subjects with premature ejaculation (PE).

Active, not recruiting

Oct 200840 participants

A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejaculation (PE)

Active, not recruiting

Nov 2007300 participants

A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PSD502 in subjects with Premature Ejaculation (PE)

Active, not recruiting

Nov 2007300 participants

A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejaculation (PE)

Active, not recruiting

Oct 2007300 participants

Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation

Oct 2007256 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials10
Approvals
News

Back to Organizations